552831-23-9

Basic information

• Product Name: [(3R)-quinuclidin-3-yl] imidazole-1-carboxylate
• Synonyms: (3R)-1-Azabicyclo[2.2.2]oct-3-yl 1H-imidazole-1-carboxylate
• CAS NO: 552831-23-9
• Molecular Formula: C₁₁H₁₅N₃O₂
• Molecular Weight: 221.26
• Mol File: 552831-23-9.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 364.4°C at 760 mmHg
• Flash Point: 174.2°C
• Density: 1.43g/cm³
• Vapor Pressure: 1.69E-05mmHg at 25°C
• Refractive Index: 1.687
• CAS DataBase Reference: [(3R)-quinuclidin-3-yl] imidazole-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: [(3R)-quinuclidin-3-yl] imidazole-1-carboxylate(552831-23-9)
• EPA Substance Registry System: [(3R)-quinuclidin-3-yl] imidazole-1-carboxylate(552831-23-9)

Safety Data

• Hazardous Substances Data: 552831-23-9(Hazardous Substances Data)

Upstream product

• 530-62-1 1,1'-carbonyldiimidazole 
• 25333-42-0 (R)-quinuclidin-3-ol 

Downstream Products

• 1172614-00-4 (S)-((R)-quinuclidin-3-yl) 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate hydrogensulfate 
• 180272-14-4 (S,R)-((R)-quinuclidin-3-yl) 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate 
• 740780-79-4 (3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate 
• 242478-37-1 solifenacin 
• 1262506-09-1 solifenacin succinate 
• 1416618-74-0 (R)-quinuclidin-3-yl phenethylcarbamate 
• 385367-47-5 Tarafenacin 
• 1207275-05-5 carbonic acid (R)-(1-aza-bicyclo[2.2.2]oct-3-yl)ester (3-fluoro-phenyl)-(2-fluoro-phenyl)-methyl ester 
• 1207274-75-6 carbonic acid (R)-1-aza-bicyclo[2.2.2]oct-3-yl ester bis-(3-fluoro-phenyl)-methyl ester 

Relevant articles and documents

Process for the Preparation of Solifenacin and Salts Thereof

The invention provides a new process for the preparation of solifenacin or a pharmaceutically acceptable acid addition salt thereof, comprising reacting (R)-quinuclidin-3-yl phenethylcarbamate with benzaldehyde in the presence of an acid to obtain a diast

QUINUCLIDINE CARBONATE SALTS AND MEDICINAL COMPOSITION THEREOF

Quinuclidine carbonate derivatives act as muscarinic receptor antagonists and are effective for the prevention and/or treatment of a broncho-obstructive or inflammatory diseases.